Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Jun 2, 2020	8-K
DEFA14A	May 19, 2020	DEFA14A
10-Q	May 7, 2020	10-Q
UPLOAD	Apr 30, 2020
DEFM14A	Apr 29, 2020	DEFM14A
CORRESP	Apr 27, 2020
PRER14A	Apr 27, 2020	PRER14A
8-K	Apr 24, 2020	8-K
UPLOAD	Apr 24, 2020
CORRESP	Apr 10, 2020
PRER14A	Apr 10, 2020	PRER14A
UPLOAD	Apr 6, 2020
8-K	Mar 9, 2020	8-K
DEFA14A	Mar 9, 2020	8-K
PREM14A	Mar 6, 2020	PREM14A
S-8	Mar 5, 2020	S-8
10-K	Mar 5, 2020	10-K
8-K	Mar 5, 2020	8-K
SC 13G/A	Feb 14, 2020
SC 13G	Feb 14, 2020	ZAFGEN
SC 13G/A	Feb 14, 2020
SC 13G/A	Feb 14, 2020
SC 13G/A	Feb 13, 2020	AMENDMENT NO. 1 TO THE SCHEDULE 13G
SC 13G	Feb 12, 2020
SC 13G	Feb 11, 2020	SC 13G

← Newer Page 14 of 28 · 696 filings Older →